SCHEMBL22721963

SCHEMBL22721963

Cc1nc(C)c(C=Cc2ccccc2Cl)nc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHAT P28329 1/20 0.45
▸ CYP1A2 P05177 2/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ NFE2L2 Q16236 1/20 0.44
▸ MAPT P10636 5/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ APOBEC3A P31941 1/20 0.42
▸ APOBEC3G Q9HC16 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22721962 1.00 CHAT (0.45) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL9665072 0.81 ALDH1A1 (0.50) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL9000491 0.81 ALDH1A1 (0.50) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL28053936 0.77 PTGS1 (0.50) CHATKDM4ERAB9ALMNATP53
SCHEMBL28826352 0.76 TXNRD1 (0.56) CYP1A2CYP1A1CYP1B1NFE2L2MAPT
SCHEMBL9586694 0.76 ALDH1A1 (0.62) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL1058814 0.76 ALDH1A1 (0.62) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL4714523 0.73 MEN1 (0.47) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL7262198 0.73 FGFR1 (0.44) CHATCYP1A2CYP1A1CYP1B1RELA
SCHEMBL7262186 0.73 CYP1A2 (0.43) CHATCYP1A2CYP1A1CYP1B1RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020242225-A1 COMPOSITION FOR PREVENTING OR TREATING PROTEIN CONFORMATIONAL DISORDERS, COMPRISING IRE1α KINASE ACTIVATOR AS ACTIVE INGREDIENT 연세대학교 산학협력단 2020-12-03 — — WO disclosed
Send feedback